Registered number: 11864600

Kleiser Ltd
Unaudited Financial Statements
for the year ended 31 March 2023

Statement of Financial Position

as at 31 March 2023

  2023
2022
   
££
 
££
Called up share capital not paid  
  -  
 
  -  
Fixed assets  
  -  
 
  -  
Current assets  
30,540    
 
37,377    
Prepayments and accrued income  
-    
 
-    
Creditors: amounts falling due within one year  
-    
 
( 18 )  
Net current assets (liabilities)  
  30,540  
 
  37,359  
Total assets less current liabilities  
  30,540  
 
  37,359  
Creditors: amounts falling due after more than one year  
  -  
 
  -  
Provisions for liabilities  
  -  
 
  -  
Accruals and deferred income  
  -  
 
  -  
Net assets  
  30,540  
 
  37,359  
   
Capital and reserves  
  30,540  
 
  37,359  

xbrli:pure 11864600 2022-04-01 2023-03-31 11864600 2021-04-01 2022-03-31 11864600 2023-03-31 11864600 2022-03-31 11864600 2022-04-01 11864600 uk-frs102:WithinOneYear 2023-03-31 11864600 uk-frs102:AfterOneYear 2023-03-31 11864600 uk-frs102:WithinOneYear 2022-03-31 11864600 uk-frs102:AfterOneYear 2022-03-31 11864600 uk-bus:AuditExempt-NoAccountantsReport 2022-04-01 2023-03-31 11864600 uk-bus:FilletedAccounts 2022-04-01 2023-03-31 11864600 uk-bus:Director1 1 2022-04-01 2023-03-31 11864600 uk-bus:Director1 2022-04-01 2023-03-31 11864600 uk-bus:Director1 1 2022-04-01 11864600 uk-bus:Director1 1 2023-03-31 11864600 uk-bus:Micro-entities 2022-04-01 2023-03-31 11864600 uk-bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 iso4217:GBP 11864600 countries:EnglandWales 2022-04-01 2023-03-31 11864600 uk-bus:RegisteredOffice 2022-04-01 2023-03-31

Footnotes to the Statement of Financial Position

Ruth Davies

1. Arrangements not included in Statement of Financial Position

The company has not entered into any arrangements not shown on the Statement of Financial Position.

2. Average number of employees

The average number of employees in the period was 1.

3. Directors’ benefits: advances, credit and guarantees

Ruth Davies

Included in debtors is an amount payable to the company by one of its directors. The amount is an advance of £11,449 made to Ruth Davies, a director of the company, on 24/03/2023.

During the accounting year the maximum amount payable by Ruth Davies was £11,449

The following conditions are attached to the amount payable by Ruth Davies:

  • There is no interest due to be paid on any outstanding amount
  • No fixed date has been set for the amount to be repaid to the company.
Opening balance 01/04/2022 Additional advance Amount repaid Amount written off Amounts waived Interest payable Closing balance 31/03/2023
£ £ £ £ £ £ £
18   ( 11,467 )
( 11,467 )
0
0  
0 0 0 ( 11,449 )

4. Guarantees, contingencies and other financial commitments

There are no guarantees, contingencies or other commitments not included in the financial statements.

Statutory Statements

In accordance with section 414(3) of the Companies Act 2006, these accounts have been prepared in accordance with the FRS 105: The Financial Reporting Standard applicable to the Micro-entities Regime for periods commencing on or after 1 January 2016. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

For the year ending 31/03/2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of Companies Act 2006 with respect to accounting records and the preparation of accounts

Company information

a) The company is registered in England and Wales

b) Company registration number - 11864600

c) The company is a private company and is limited by shares

d) The companies registered office address is 4 Alexandra Road, St. Albans, AL1 3AZ, United Kingdom



Approved by the board of directors and signed on behalf of the board,

Kleiser Ltd
Director Ruth Davies
Date of approval: 04/03/2024
The company was trading for the entire period 2022-04-01 2023-03-31 2023-03-31 Clinical Trials, Pharmaceutical company work, project manage clinical trials 2024-03-04 2024-03-04